Intermountain to lead AI-driven research aiming to improve care for critically-ill patients

As part of the National Institutes of Health’s Acute Respiratory Distress Syndrome, Pneumonia and Sepsis Phenotyping Consortium, Intermountain Health will help lead the use of artificial intelligence technologies to better understand the dissimilarities and underlying mechanisms of critical illness syndromes in order to foster a new treatment paradigm.

WHY IT MATTERS

A new NIH grant of $51.6 million grant will fund the APS Phenotyping…